<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2023//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_230101.dtd">
<PubmedArticleSet>
<PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Automated"><PMID Version="1">37335678</PMID><DateCompleted><Year>2023</Year><Month>06</Month><Day>21</Day></DateCompleted><DateRevised><Year>2023</Year><Month>06</Month><Day>21</Day></DateRevised><Article PubModel="Print"><Journal><ISSN IssnType="Electronic">1536-5964</ISSN><JournalIssue CitedMedium="Internet"><Volume>102</Volume><Issue>23</Issue><PubDate><Year>2023</Year><Month>Jun</Month><Day>09</Day></PubDate></JournalIssue><Title>Medicine</Title><ISOAbbreviation>Medicine (Baltimore)</ISOAbbreviation></Journal><ArticleTitle>A case report: Catatonic symptoms secondary to systemic lupus erythematosus with multiple infections: neuropsychiatric or "mimickers?".</ArticleTitle><Pagination><StartPage>e33746</StartPage><MedlinePgn>e33746</MedlinePgn></Pagination><ELocationID EIdType="pii" ValidYN="Y">e33746</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.1097/MD.0000000000033746</ELocationID><Abstract><AbstractText Label="RATIONALE" NlmCategory="BACKGROUND">Systemic lupus erythematosus (SLE) is frequently accompanied by neuropsychiatric (NP) manifestations. However, typical symptoms of catatonia are uncommon. Neuropsychiatric SLE or its "mimickers" may cause NP symptoms, making differential diagnosis a significant challenge in clinical practice.</AbstractText><AbstractText Label="PATIENT CONCERNS" NlmCategory="METHODS">A 68-year-old female with SLE was hospitalized for edema, lung infection, and recurrent fungal mouth ulcers after multiple courses of cortisol and immunosuppressive therapy. Five days after admission, stupor, immobility, mutism, and rigidity were observed.</AbstractText><AbstractText Label="DIAGNOSIS" NlmCategory="METHODS">"Mimickers": catatonic disorder due to a general medical condition.</AbstractText><AbstractText Label="INTERVENTION" NlmCategory="METHODS">Initially, relevant laboratory tests, imaging studies, and the disease activity index score were performed. A survey of the causes of the disease was conducted among the patient's relatives. Subsequently, we discontinued moxifloxacin, corticosteroids, fluconazole, and other medications and inserted a gastric tube for nutritional support. During this process, traditional Chinese medicine and acupuncture have been utilized.</AbstractText><AbstractText Label="OUTCOMES" NlmCategory="RESULTS">After 3 days, the patient recovered and only complained of fatigue.</AbstractText><AbstractText Label="CONCLUSION" NlmCategory="CONCLUSIONS">When SLE presents with NP symptoms, it is essential to make a correct diagnosis in order to guide appropriate treatment by actively searching for inducers and clinical, laboratory, and neuroradiological characteristics that can aid in the differential diagnosis. When treatment options are limited, it can be beneficial to try a variety of combination strategies, such as traditional Chinese medicine and acupuncture.</AbstractText><CopyrightInformation>Copyright &#xa9; 2023 the Author(s). Published by Wolters Kluwer Health, Inc.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Lv</LastName><ForeName>Lizeyu</ForeName><Initials>L</Initials><Identifier Source="ORCID">0000-0001-9343-7348</Identifier><AffiliationInfo><Affiliation>School of Clinical Medicine, Chengdu University of Traditional Chinese Medicine, Chengdu, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Lin</LastName><ForeName>Yong</ForeName><Initials>Y</Initials><AffiliationInfo><Affiliation>School of Clinical Medicine, Chengdu University of Traditional Chinese Medicine, Chengdu, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Zhang</LastName><ForeName>Yu</ForeName><Initials>Y</Initials><AffiliationInfo><Affiliation>School of Clinical Medicine, Chengdu University of Traditional Chinese Medicine, Chengdu, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Xiao</LastName><ForeName>Wen</ForeName><Initials>W</Initials><AffiliationInfo><Affiliation>Department of Neuropsychiatrics, Hospital of Chengdu University of Traditional Chinese Medicine, Chengdu, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Li</LastName><ForeName>Mingquan</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Department of Nephrology, Hospital of Chengdu University of Traditional Chinese Medicine, Chengdu, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Zhao</LastName><ForeName>Liangbin</ForeName><Initials>L</Initials><Identifier Source="ORCID">0000-0003-2867-4915</Identifier><AffiliationInfo><Affiliation>Department of Nephrology, Hospital of Chengdu University of Traditional Chinese Medicine, Chengdu, China.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D002363">Case Reports</PublicationType><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>Medicine (Baltimore)</MedlineTA><NlmUniqueID>2985248R</NlmUniqueID><ISSNLinking>0025-7974</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D000305">Adrenal Cortex Hormones</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000368" MajorTopicYN="N">Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D002389" MajorTopicYN="Y">Catatonia</DescriptorName><QualifierName UI="Q000175" MajorTopicYN="N">diagnosis</QualifierName><QualifierName UI="Q000209" MajorTopicYN="N">etiology</QualifierName><QualifierName UI="Q000628" MajorTopicYN="N">therapy</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D008180" MajorTopicYN="Y">Lupus Erythematosus, Systemic</DescriptorName><QualifierName UI="Q000150" MajorTopicYN="N">complications</QualifierName><QualifierName UI="Q000175" MajorTopicYN="N">diagnosis</QualifierName><QualifierName UI="Q000188" MajorTopicYN="N">drug therapy</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D020945" MajorTopicYN="Y">Lupus Vasculitis, Central Nervous System</DescriptorName><QualifierName UI="Q000175" MajorTopicYN="N">diagnosis</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D001523" MajorTopicYN="Y">Mental Disorders</DescriptorName><QualifierName UI="Q000175" MajorTopicYN="N">diagnosis</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000305" MajorTopicYN="N">Adrenal Cortex Hormones</DescriptorName><QualifierName UI="Q000627" MajorTopicYN="N">therapeutic use</QualifierName></MeshHeading></MeshHeadingList><CoiStatement>The authors have no conflicts of interest to disclose.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="medline"><Year>2023</Year><Month>6</Month><Day>21</Day><Hour>6</Hour><Minute>42</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2023</Year><Month>6</Month><Day>19</Day><Hour>13</Hour><Minute>8</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2023</Year><Month>6</Month><Day>19</Day><Hour>12</Hour><Minute>3</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">37335678</ArticleId><ArticleId IdType="pmc">PMC10256366</ArticleId><ArticleId IdType="doi">10.1097/MD.0000000000033746</ArticleId><ArticleId IdType="pii">00005792-202306090-00052</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Zucchi D, Elefante E, Schilir&#xf2; D, et al. . One year in review 2022: systemic lupus erythematosus. Clin Exp Rheumatol. 2022;40:4&#x2013;14.</Citation><ArticleIdList><ArticleId IdType="pubmed">35088691</ArticleId></ArticleIdList></Reference><Reference><Citation>Carri&#xf3;n-Barber&#xe0; I, Salman-Monte TC, V&#xed;lchez-Oya F, et al. . Neuropsychiatric involvement in systemic lupus erythematosus: a review. Autoimmun Rev. 2021;20:102780.</Citation><ArticleIdList><ArticleId IdType="pubmed">33609799</ArticleId></ArticleIdList></Reference><Reference><Citation>Caroff SN, Ungvari GS, Gazdag G. Treatment of schizophrenia with catatonic symptoms: a narrative review. Schizophr Res. 2022. doi: 10.1016/j.schres.2022.11.015.</Citation><ArticleIdList><ArticleId IdType="pubmed">36404216</ArticleId></ArticleIdList></Reference><Reference><Citation>Walther S, Strik W. Catatonia. CNS Spectr. 2016;21:341&#x2013;8.</Citation><ArticleIdList><ArticleId IdType="pubmed">27255726</ArticleId></ArticleIdList></Reference><Reference><Citation>Jaimes-Albornoz W, Serra-Mestres J. Prevalence and clinical correlations of catatonia in older adults referred to a liaison psychiatry service in a general hospital. Gen Hosp Psychiatry. 2013;35:512&#x2013;6.</Citation><ArticleIdList><ArticleId IdType="pubmed">23684045</ArticleId></ArticleIdList></Reference><Reference><Citation>Sienaert P, Dhossche DM, Vancampfort D, et al. . A clinical review of the treatment of catatonia. Review. Front Psychiatry. 2014;5:181. doi: 10.3389/fpsyt.2014.00181.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4260674</ArticleId><ArticleId IdType="pubmed">25538636</ArticleId></ArticleIdList></Reference><Reference><Citation>Pamfil C, Fanouriakis A, Damian L, et al. . EULAR recommendations for neuropsychiatric systemic lupus erythematosus vs usual care: results from two European centres. Rheumatology (Oxford). 2015;54:1270&#x2013;8.</Citation><ArticleIdList><ArticleId IdType="pubmed">25638807</ArticleId></ArticleIdList></Reference><Reference><Citation>Hanly JG. Diagnosis and management of neuropsychiatric SLE. Nat Rev Rheumatol. 2014;10:338&#x2013;47.</Citation><ArticleIdList><ArticleId IdType="pubmed">24514913</ArticleId></ArticleIdList></Reference><Reference><Citation>Sarwar S, Mohamed AS, Rogers S, et al. . Neuropsychiatric systemic lupus erythematosus: a 2021 update on diagnosis, management, and current challenges. Cureus. 2021;13:e17969.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8516357</ArticleId><ArticleId IdType="pubmed">34667659</ArticleId></ArticleIdList></Reference><Reference><Citation>de Amorim JC, Frittoli RB, Pereira D, et al. . Epidemiology, characterization, and diagnosis of neuropsychiatric events in systemic lupus erythematosus. Expert Rev Clin Immunol. 2019;15:407&#x2013;16.</Citation><ArticleIdList><ArticleId IdType="pubmed">30632405</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang M, Wang Z, Zhang S, et al. . Progress in the pathogenesis and treatment of neuropsychiatric systemic lupus erythematosus. J Clin Med. 2022;11. doi: 10.3390/jcm11174955.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9456588</ArticleId><ArticleId IdType="pubmed">36078885</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle></PubmedArticleSet>